Multi-Sector Approaches on Improving Access to ARVs in China
in Book: Intellectual Property Rights and Access to Arv Medicines: Civil Society Resistance in the Global South, Chapter 3, Page 82-110
35 Pages Posted: 22 May 2018
Date Written: July 6, 2009
Since China launched its national HIV/AIDS treatment program in 2003, the issue of ARV access has become a major obstacle to expanding treatment and prolonging patients’ lives. Examining the efforts and limitations of multiple stakeholders in the process of attaining full access to ARVs in China, this paper presents and analyzes the problems surrounding ARV access in China from different standpoints, focusing on the epidemic situation, capacities and constraints on domestic production, legal and policy barriers hampering access to ARVs, and noteworthy civil society responses and advocacy for ARV access. This paper not only describes how national stakeholders play their respective roles in the process of reaching national objectives in terms of access to ARVs, but also offers a comparative view of international stakeholders and practices respectively.This comparison in turn assists us in exploring and testing out ways for China to overcome the obstacles blocking access to ARVs.
Keywords: intellectual property, patent law, access to medicines, China
Suggested Citation: Suggested Citation